Pre-hospital metoprolol administration in Killip-class I–II anterior ST-segment elevation acute myocardial infarction is safe and reduces infarct size and adverse events. Insights from the METOCARD-CNIC trial

Alonso Mateos, Ines Garcia,J M Garcia,Juan Valenciano,Pilar Huertas,Jose Antonio Iglesias,M J Fernandez, R J Rodriguez Fernandez, Borja Ruiz,Jesus Bravo, A Garcia, Leticia Fernandez, Antonio Maestro Fernandez, A Alvarez Albarran,Andres Iniguez,Ervigio Corral,Carlos Macaya,Valentin Fuster,Vicente Martin Sanchez,Borja Ibanez

Resuscitation（2014）

引用 0|浏览50

暂无评分

摘要

Objective: Pre-reperfusion administration of i.v. metoprolol has been shown to reduce infarct size in Killip-class I–II anterior ST-segment elevation myocardial infarction (STEMI) patients undergoing primary angioplasty (METOCARD-CNIC trial, Circulation 2013). The objective of the present study was to study the effects of i.v. metoprolol administration in the pre-hospital emergency care environment.

查看译文

关键词

acute myocardial infarction,myocardial infarction,infarction size,pre-hospital,killip-class,st-segment,metocard-cnic

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要